While data suggests the flu season may have passed its peak, caution is still advised, especially with kids back in school.
Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) (“Cardiol” or the “Company”), a late-stage life sciences company focused on advancing ...